Focus: Variational AI is a small molecule drug discovery biotech founded in 2019 and based in Vancouver, BC, leveraging computational approaches to accelerate early-stage drug development. The company operates as a pre-revenue stage biotech focused on the discovery phase of pharmaceutical development.
Profile data last refreshed 13h ago · AI intelligence enriched 2w ago
Stable — net -2 jobs in 30d
0 added, 2 removed. Backfill posture.
Variational AI is a speculative early-stage bet best suited for founders, risk-tolerant R&D scientists, or those seeking to build company infrastructure from scratch; not recommended for professionals prioritizing financial stability or established career ladders.
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Help build intelligence for Variational AI
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Generated by Claude from Variational AI's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
Based on last 4 crawl cycles
Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.
Upgrade to Pro — $25/mo